Patent assignee · GB · COMPANY

GW Research Limited

48Patents
48Active
48Granted
59Portfolio score

Filing activity: Jun 10, 2013 → May 19, 2023

Most-cited patents

PatentTitleAreaCited byStatus
US10709671B2 Use of cannabinoids in the treatment of epilepsy Performing Operations; Transporting 45 Active
US10918608B2 Use of cannabidiol in the treatment of epilepsy Human Necessities 45 Active
US10709674B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 44 Active
US10849860B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 44 Active
US10603288B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 44 Active
US10709673B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 44 Active
US10966939B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 43 Active
US11065209B2 Use of cannabidiol in the treatment of epilepsy Human Necessities 39 Active
US11207292B2 Cannabidiol preparations and its uses Human Necessities 38 Active
US11096905B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 38 Active
US11154516B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 38 Active
US11160795B2 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus Human Necessities 34 Active
US11154517B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 34 Active
US11065227B2 Use of cannabinoids in the treatment of multiple myeloma Human Necessities 34 Active
US10098867B2 Use of phytocannabinoids in the treatment of ovarian carcinoma Human Necessities 32 Active
US10765643B2 Use of cannabidiol in the treatment of epilepsy Human Necessities 31 Active
US10583096B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 30 Active
US11311498B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 29 Active
US11160757B1 pH dependent release coated microparticle cannabinoid formulations Human Necessities 28 Active
US11147776B2 7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy Human Necessities 28 Active
US11147783B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 26 Active
US11357741B2 Use of cannabinoids in the treatment of epilepsy Performing Operations; Transporting 26 Active
US11400055B2 Use of cannabidiol in the treatment of epilepsy Human Necessities 25 Active
US11229612B2 Parenteral formulations Human Necessities 25 Active
US11446258B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 24 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.